Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000942794-00-000015
Filing Date
2000-04-24
Accepted
2000-04-24 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 S-3 48418
  Complete submission text file 0000942794-00-000015.txt   50012
Mailing Address 175 CROSSING BOULEVARD FRAMINGHAM MA 01702
Business Address 175 CROSSING BLVD BIOTECHNOLOGY RESEARCH PARK FRAMINGHAM MA 01702 5087975777
AQUILA BIOPHARMACEUTICALS INC (Filer) CIK: 0000704292 (see all company filings)

EIN.: 043307818 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-35480 | Film No.: 607459
SIC: 2835 In Vitro & In Vivo Diagnostic Substances